In previous studies it has been demonstrated
that the plant alkaloid
voacamine (1), used at noncytotoxic concentrations, enhanced
the cytotoxicity of doxorubicin and exerted a chemosensitizing effect
on cultured multidrug-resistant (MDR) U-2 OS-DX osteosarcoma cells.
The in vitro investigations reported herein gave the following results:
(i) the chemosensitizing effect of 1, in terms of drug
accumulation and cell survival, was confirmed using SAOS-2-DX cells,
another MDR osteosarcoma cell line; (ii) compound 1 enhanced
the cytotoxic effect of doxorubicin also on the melanoma cell line
Me30966, intrinsically drug resistant and P-glycoprotein-negative;
(iii) at the concentrations used to sensitize tumor cells, 1 was not cytotoxic to normal cells (human fibroblasts). These findings
suggest possible applications of voacamine (1) in integrative
oncologic therapies against resistant tumors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.